Verition Fund Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,471
Closed -$278K 1622
2016
Q4
$278K Sell
3,471
-1,694
-33% -$134K 0.02% 871
2016
Q3
$412K Sell
5,165
-4,264
-45% -$344K 0.04% 593
2016
Q2
$735K Sell
9,429
-28,585
-75% -$2.04M 0.09% 254
2016
Q1
$2.09M Sell
38,014
-11,432
-23% -$623K 0.34% 54
2015
Q4
$3.05M Buy
+49,446
New +$3.12M 0.58% 38
2015
Q2
Sell
-23,874
Closed -$1.56M 782
2015
Q1
$1.56M Buy
+23,874
New +$1.59M 0.18% 35
2014
Q4
Sell
-11,017
Closed -$662K 781
2014
Q3
$662K Buy
+11,017
New +$720K 0.09% 177
2014
Q2
Sell
-4,358
Closed -$285K 850
2014
Q1
$285K Buy
4,358
+813
+23% +$52.9K 0.04% 289
2013
Q4
$220K Sell
3,545
-5,419
-60% -$314K 0.04% 372
2013
Q3
$481K Buy
+8,964
New +$462K 0.07% 218

Other funds holding STJ

Verition Fund Management's STJ Position: Q1 2017 in Review

Verition Fund Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,471 shares — an estimated $278K sold.

Verition Fund Management first reported a position in STJ in Q3 2013 and held it in 10 quarters. The position peaked at $3.05M in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Verition Fund Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Verition Fund Management sold 3,471 St Jude Medical shares in Q1 2017, an estimated $278K.
  • Verition Fund Management first reported a position in St Jude Medical in Q3 2013 and held it in 10 quarters.
  • Verition Fund Management's St Jude Medical position peaked at $3.05M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Verition Fund Management's 13F filing for Q1 2017, filed 15 May 2017.